Intravenous Fluid for Pediatric Migraine in the Emergency Department (EDMigraine3)

• Nausea [ Time Frame: 30 minutes ] [ Designated as safety issue: Yes ]
  Severity will be assessed using: (1) Visual Analogue Scale; (2) Four categories (none, mild, moderate, severe)
• Vomiting [ Time Frame: 30 minutes ] [ Designated as safety issue: No ]
• Use of rescue medication [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  Use of any rescue medication after leaving the Emergency Department
• Headache recurrence [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  Recurrence or worsening of headache after leaving the Emergency Department
• Return to Emergency Department [ Time Frame: 24 hours ] [ Designated as safety issue: No ]
  Return to Emergency Department for treatment of migraine within 24 hours

The purpose of this study is to evaluate the effect of intravenous fluid (0.9% sodium chloride and water) alone on headache pain in children with migraine visiting the Emergency Department.

Migraine is a common and disabling disorder for children. The pain may be severe and relatively few effective medications are approved for use in children. The Emergency Department (ED) remains an important resource for children suffering from migraine whom have not responded to their usual therapy. While a number of effective intravenous therapies have been studied in adults, there has been only one such study in children. As such, emergency physicians have little or no information about the safety and efficacy of these medications in children. However, the conduct of clinical trials where pain is the outcome measure is often limited by a high placebo-response rate. The expectation of treatment can significantly alter the response to medications especially when pain severity is the outcome measure. Moreover, the investigators have found that intravenous fluid alone may help to treat migraine headache in children. The investigators propose a study to examine the response to intravenous fluid hydration as initial therapy comparing a group with expectation of medication and another group without the initial expectation of medication. The results of the study will help to estimate the rate of response to intravenous fluid and to evaluate the placebo-effect (i.e. expectation of treatment) in studies of migraine treatment in the ED. Exposure to additional and possibly unnecessary medications will thus be minimized and the results of future trials more definitive on the effect of the study medication.

• Migraine
• Headache

• Active Comparator: Normal saline
  Intervention: Drug: Normal saline
• Experimental: Normal saline and possible medication
  Intervention: Drug: Normal saline

Inclusion Criteria:

• Diagnosis of migraine or probable migraine (with or without aura) per the International Classification of Headache Disorders (2nd edition)
• Visiting the Emergency Department for migraine treatment
• Emergency Department physician has chosen to administer intravenous medication
• Has taken usual therapy at home or at least one does of either ibuprofen or acetaminophen in the Emergency Department

Exclusion Criteria:

• Other probable cause for headache (e.g. ventriculoperitoneal shunt, neoplasm, intracranial cyst)
• Head trauma causing loss of consciousness within 1 week of presentation
• Fever (temperature > 38.5 oC)
• Signs or symptoms of meningitis